Pharmaceutical composition for oral administration

An oral pharmaceutical composition characterized in that it consists of a suspension of a platinum complex of general formula I, wherein A and A' independently of one another are an NH3 group or an amino or diamino group containing 1 to 18 carbon atoms, B and B' independently of one anothe...

Full description

Saved in:
Bibliographic Details
Main Authors SOVA PETR, FRANC ALES
Format Patent
LanguageChinese
English
Published 12.08.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An oral pharmaceutical composition characterized in that it consists of a suspension of a platinum complex of general formula I, wherein A and A' independently of one another are an NH3 group or an amino or diamino group containing 1 to 18 carbon atoms, B and B' independently of one another are a halogen atom or a hydroxy group or are an -0-C(O)-R or an -0-C(O)-R' group wherein R and R' independently of one another are hydrogen atom, an alkyl, alkenyl, aryl, aralkyl, alkylamino or alkoxy group which groups contain 1 to 10 carbon atoms, or functional derivatives of these groups, X and X' independently of one another are a halogen atom or a monocarboxylate group containing 1 to 20 carbon atoms, or X and X' together form a dicarboxylate group containing 2 to 20 carbon atoms, in at least one pharmaceutically acceptable vegetable, animal, mineral, synthetic or semisynthetic oil and/or in at least one pharmaceutically acceptable vegetable, animal, mineral, synthetic or semisynthetic oily substance, in which suspens
Bibliography:Application Number: CN200780030866